Health Sciences Research

Research Output 1992 2019

Filter
Letter
Letter
10 Citations (Scopus)

A phase Ib study of the combination of the aurora kinase inhibitor alisertib (MLN8237) and bortezomib in relapsed multiple myeloma

Rosenthal, A., Kumar, S. K., Hofmeister, C., Laubach, J., Vij, R., Dueck, A., Gano, K. & Stewart, A. K., Jul 1 2016, In : British Journal of Haematology. 174, 2, p. 323-325 3 p.

Research output: Contribution to journalLetter

Aurora Kinases
Multiple Myeloma
Recurrence
MLN 8237
Bortezomib
2 Citations (Scopus)

Dabigatran Versus Warfarin in Relation to Renal Function in Patients with Atrial Fibrillation

Munoz, F. D. C., Yao, X., Abraham, N. S., Bellolio, F., Rabinstein, A., Asirvatham, S. J., McBane, R. D., Gersh, B. J., Shah, N. D. & Noseworthy, P., Jul 5 2016, In : Journal of the American College of Cardiology. 68, 1, p. 129-131 3 p.

Research output: Contribution to journalLetter

Warfarin
Atrial Fibrillation
Kidney
Dabigatran
2 Citations (Scopus)

Does Participation in the ACS-NSQIP Improve Outcomes?

Osborne, N. H. & Etzioni, D. A., Aug 1 2017, In : Annals of Surgery. 266, 2, p. e32-e33

Research output: Contribution to journalLetter

7 Citations (Scopus)

Feasibility study of online yoga for symptom management in patients with myeloproliferative neoplasms

Huberty, J., Eckert, R., Gowin, K., Mitchell, J., Dueck, A., Ginos, B. F., Larkey, L. & Mesa, R., Sep 30 2017, In : Haematologica. 102, 10, p. e384-e388

Research output: Contribution to journalLetter

Yoga
Feasibility Studies
Neoplasms
286 Citations (Scopus)

Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment

Basch, E., Deal, A. M., Dueck, A., Scher, H. I., Kris, M. G., Hudis, C. & Schrag, D., Jul 11 2017, In : JAMA - Journal of the American Medical Association. 318, 2, p. 197-198 2 p.

Research output: Contribution to journalLetter

Neoplasms
Patient Reported Outcome Measures
2 Citations (Scopus)

Patient-reported symptom monitoring during chemotherapy - Reply

Basch, E., Deal, A. M. & Dueck, A., Nov 21 2017, In : JAMA - Journal of the American Medical Association. 318, 19, p. 1935-1936 2 p.

Research output: Contribution to journalLetter

Physiologic Monitoring
Drug Therapy
Neoplasms

Perceived risk for cancer progression and psychological status in chronic lymphocytic leukemia patients: CALGB 70603 (Alliance)

Deshields, T. L., Dueck, A., Rogers, K., Brown, J. R., Shanafelt, T., Mintzer, D. & Byrd, J. C., Jan 1 2019, In : Leukemia and Lymphoma.

Research output: Contribution to journalLetter

B-Cell Chronic Lymphocytic Leukemia
Psychology
Neoplasms
2 Citations (Scopus)

Phase II trial of nab-paclitaxel in patients with relapsed or refractory multiple myeloma

Jain, T., Dueck, A., Kosiorek, H. E., Ginos, B. F., Mayo, A., Reeder, C. B., Chesi, M., Mikhael, J. R., Stewart, A. K., Bergsagel, P. L. & Fonseca, R., Dec 1 2016, In : American Journal of Hematology. 91, 12, p. E504-E505

Research output: Contribution to journalLetter

Multiple Myeloma
130-nm albumin-bound paclitaxel
27 Citations (Scopus)

The authors reply

Hartmann, L. C. & Lindor, N. M., Jun 16 2016, In : New England Journal of Medicine. 374, 24, p. 2404 1 p.

Research output: Contribution to journalLetter

12 Citations (Scopus)

Two-Year Survival Comparing Web-Based Symptom Monitoring vs Routine Surveillance Following Treatment for Lung Cancer

Denis, F., Basch, E., Septans, A. L., Bennouna, J., Urban, T., Dueck, A. & Letellier, C., Jan 22 2019, In : JAMA - Journal of the American Medical Association. 321, 3, p. 306-307 2 p.

Research output: Contribution to journalLetter

Lung Neoplasms